PubMed

Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.

Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T, Owens DR.

Diabetes Care. 2002 Aug;25(8):1271-6.PMID: 12145220 [PubMed - indexed for MEDLINE]Related articlesFree article

Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.

Cozma LS, Luzio SD, Dunseath GJ, Underwood PM, Owens DR.

Diabetes Care. 2005 May;28(5):1001-7.PMID: 15855557 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.

Owens DR, Luzio SD, Ismail I, Bayer T.

Diabetes Care. 2000 Apr;23(4):518-23.PMID: 10857945 [PubMed - indexed for MEDLINE]Related articlesFree article

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

Damsbo P, Clauson P, Marbury TC, Windfeld K.

Diabetes Care. 1999 May;22(5):789-94.PMID: 10332683 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide.

Schmitz O, Lund S, Andersen PH, Jønler M, Pørksen N.

Diabetes Care. 2002 Feb;25(2):342-6.PMID: 11815507 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes.

Go EH, Kyriakidou-Himonas M, Berelowitz M.

Diabetes Metab Res Rev. 2004 May-Jun;20(3):225-31.PMID: 15133754 [PubMed - indexed for MEDLINE]Related articles

Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes.

Hollingdal M, Sturis J, Gall MA, Damsbo P, Pincus S, Veldhuis JD, Pørksen N, Schmitz O, Juhl CB.

Diabet Med. 2005 Oct;22(10):1408-13.PMID: 16176204 [PubMed - indexed for MEDLINE]Related articles

Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.

Abbink EJ, van der Wal PS, Sweep CG, Smits P, Tack CJ.

Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):466-71.PMID: 15386823 [PubMed - indexed for MEDLINE]Related articles

Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.

Yngen M, Ostenson CG, Hjemdahl P, Wallén NH.

Diabet Med. 2006 Feb;23(2):134-40.PMID: 16433710 [PubMed - indexed for MEDLINE]Related articles

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.

Li J, Tian H, Li Q, Wang N, Wu T, Liu Y, Ni Z, Yu H, Liang J, Luo R, Li Y, Huang L.

Diabetes Obes Metab. 2007 Jul;9(4):558-65.PMID: 17587398 [PubMed - indexed for MEDLINE]Related articles

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.

Madsbad S, Kilhovd B, Lager I, Mustajoki P, Dejgaard A; Scandinavian Repaglinide Group.

Diabet Med. 2001 May;18(5):395-401.PMID: 11472451 [PubMed - indexed for MEDLINE]Related articles

Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study.

Rizzo MR, Barbieri M, Grella R, Passariello N, Paolisso G.

Diabetes Metab. 2005 Jun;31(3 Pt 1):255-60.PMID: 16142016 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Owens DR.

Diabet Med. 1998;15 Suppl 4:S28-36. Review.PMID: 9868989 [PubMed - indexed for MEDLINE]Related articles

Repaglinide administration improves brachial reactivity in type 2 diabetic patients.

Manzella D, Grella R, Abbatecola AM, Paolisso G.

Diabetes Care. 2005 Feb;28(2):366-71.PMID: 15677794 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes.

Van Gaal LF, Van Acker KL, De Leeuw IH.

Diabetes Res Clin Pract. 2001 Sep;53(3):141-8.PMID: 11483229 [PubMed - indexed for MEDLINE]Related articles

A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas.

Landgraf R, Bilo HJ, Müller PG.

Eur J Clin Pharmacol. 1999 May;55(3):165-71.PMID: 10379630 [PubMed - indexed for MEDLINE]Related articles

Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.

Rosak C, Hofmann U, Paulwitz O.

Diabetes Nutr Metab. 2004 Jun;17(3):137-42.PMID: 15334790 [PubMed - indexed for MEDLINE]Related articles

The acute effect of preprandial exogenous and endogenous sulphonylurea-stimulated insulin secretion on postprandial glucose excursions in patients with type 2 diabetes.

Groop PH, Melander A, Groop LC.

Diabet Med. 1993 Aug-Sep;10(7):633-7.PMID: 8403824 [PubMed - indexed for MEDLINE]Related articles